The Food and Drug Administration…
The Food and Drug Administration today announced a plan to [...]
Nine months after closing a $450…
Nine months after closing a $450 million fundraise, Atlas Venture [...]
AC Immune is reducing its…
AC Immune is reducing its workforce by around 30% and [...]
Enveda has closed its second $150…
Enveda has closed its second $150 million financing round of [...]
A phase 3 trial of Sanofi’s…
A phase 3 trial of Sanofi’s eczema prospect amlitelimab has [...]
An interim analysis reported in…
An interim analysis reported in June showed that Amgen’s Zai [...]
Gilead Sciences’ Kite Pharma has…
Gilead Sciences’ Kite Pharma has cut off a collaboration with [...]
After becoming the first group to…
After becoming the first group to therapeutically edit human RNA [...]
After throwing down $70 million…
After throwing down $70 million upfront to partner on Black [...]
Boston-based Radiance Biopharma is…
Boston-based Radiance Biopharma is doling out $15 million in cash [...]